Top Stories
The company has submitted its 3D Intelligence algorithm to the FDA, offering users more flexibility based on their individual insulin needs.
Quicktome Deep Brain uses a patient’s own imaging to show where implanted leads sit and map the brain pathways around them, helping guide DBS surgery and follow-up programming.
The dataset will combine disease-specific genomes with treatment histories, pathology, imaging and patient outcomes, with general availability planned for mid-2027.
The proposals call for staged authorisations, continuous monitoring and greater transparency as AI becomes more widely used across the NHS.
The tech giant's new Apple Watch Series 12 and Ultra 4 models will measure a user's heart rate every five seconds and heart rate variability every five minutes.
Conference News
OXFORD, England, Sept. 14, 2026 /PRNewswire/ -- Albus Health today announced new findings from Leiden University Medical Centre showing that nocturnal cough, measured passively at home using the Albus...
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpointMeeting with FDA planned on October 1st to align on RAD101Phase 3 pivotal trial proto...
Autoimmune diseases are characterized by high unmet medical need with most current treatments only addressing symptoms. Evaxion will apply AI-Immunology™ to target underlying pathologiesThe unique cap...
PITTSBURGH, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Catalyst MedTech today announced it will showcase its expanded nuclear cardiology portfolio at the 31st Annual Scientific Session & Exhibition of the Ame...
PHILADELPHIA, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Proscia® today announced that Unilabs, one of the leading providers of medical diagnostic services in Europe, is leveraging the Concentriq® platform to...
